Sartorius Stedim Biotech SA Cash Flow-to-Debt Ratio
Sartorius Stedim Biotech SA cash flow-to-debt ratio. Sartorius Stedim Biotech SA (DIM) has a Cash Flow-to-Debt Ratio of 0.04x as of June 2026, meaning its operating cash flow of €129.50 Million could theoretically repay 0% of its total liabilities (€3.67 Billion) in one year. Check Sartorius Stedim Biotech SA (DIM) total reinvestment rate to assess the company's total reinvestment commitment from operating cash flow.
CF-to-Debt Ratio
Operating Cash Flow
Total Liabilities
Data as of
Cash Flow-to-Debt Ratio of Sartorius Stedim Biotech SA (2005–2025)
Cash flow-to-debt ratio of Sartorius Stedim Biotech SA from 2005 to 2025. Historical debt coverage capacity for Sartorius Stedim Biotech SA across 21 annual periods. Check Sartorius Stedim Biotech SA (DIM) cash earnings ratio to evaluate the quality of earnings relative to operating cash generation.
Sartorius Stedim Biotech SA Cash Flow-to-Debt Ratio by Year (2005–2025)
Sartorius Stedim Biotech SA cash flow-to-debt ratio by year from 2005 to 2025. Year-by-year debt coverage analysis for Sartorius Stedim Biotech SA. For the full cash flow conversion analysis, see DIM operating cash flow.
| Year | CF-to-Debt Ratio | Operating CF (EUR) | Total Liabilities | YoY Change |
|---|---|---|---|---|
| 2025 | 0.14x | €538.60 Million | €3.89 Billion | ▼ -28.1% |
| 2024 | 0.19x | €815.10 Million | €4.23 Billion | ▲ +30.7% |
| 2023 | 0.15x | €746.40 Million | €5.07 Billion | ▼ -38.6% |
| 2022 | 0.24x | €612.30 Million | €2.55 Billion | ▼ -23.5% |
| 2021 | 0.31x | €695.97 Million | €2.22 Billion | ▲ +19.4% |
| 2020 | 0.26x | €416.88 Million | €1.59 Billion | ▼ -45.5% |
| 2019 | 0.48x | €310.13 Million | €642.79 Million | ▲ +11.8% |
| 2018 | 0.43x | €227.29 Million | €526.59 Million | ▲ +29.6% |
| 2017 | 0.33x | €174.69 Million | €524.45 Million | ▼ -8.1% |
| 2016 | 0.36x | €156.66 Million | €432.29 Million | ▲ +6.3% |
| 2015 | 0.34x | €142.79 Million | €418.92 Million | ▲ +12.8% |
| 2014 | 0.30x | €111.31 Million | €368.25 Million | ▲ +30.6% |
| 2013 | 0.23x | €90.11 Million | €389.39 Million | ▲ +69.9% |
| 2012 | 0.14x | €48.93 Million | €359.14 Million | ▼ -26.9% |
| 2011 | 0.19x | €60.59 Million | €325.04 Million | ▼ -25.4% |
| 2010 | 0.25x | €72.76 Million | €291.27 Million | ▼ -25.3% |
| 2009 | 0.33x | €91.86 Million | €274.66 Million | ▲ +98.8% |
| 2008 | 0.17x | €47.23 Million | €280.70 Million | ▲ +79.7% |
| 2007 | 0.09x | €26.02 Million | €277.96 Million | ▼ -62.3% |
| 2006 | 0.25x | €51.72 Million | €208.41 Million | ▲ +21.2% |
| 2005 | 0.20x | €43.85 Million | €214.18 Million | — |